Related Experiment Videos
Pathological findings of HIV-associated cardiovascular disease
G d'Amati1, C R di Gioia, P Gallo
1Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy. giulia.damati@uniroma1.it
Insights
Effective therapies have increased survival for patients with human immunodeficiency virus (HIV), leading to more long-term complications. This review examines cardiovascular pathology in HIV patients, linking morphological findings to clinical syndromes.
Area of Science:
- Cardiovascular Pathology
- Infectious Diseases
- Immunology
Background:
- Advances in antiretroviral therapy have significantly improved survival rates for individuals with human immunodeficiency virus (HIV).
- Increased longevity in HIV-positive patients has led to a greater prevalence of chronic health conditions, including cardiovascular complications.
- HIV infection itself and its treatment can directly and indirectly impact cardiovascular health.
Purpose of the Study:
- To review the spectrum of cardiovascular pathology associated with HIV infection.
- To correlate specific morphologic findings in the cardiovascular system with clinical manifestations of HIV/AIDS.
- To highlight the importance of recognizing and managing cardiovascular disease in the growing population of long-term HIV survivors.
Main Methods:
- Comprehensive literature review of studies investigating cardiovascular pathology in HIV-infected individuals.
- Analysis of morphologic findings from autopsy and biopsy studies.
- Correlation of pathological findings with reported clinical syndromes and outcomes.
- Synthesis of information on mechanisms linking HIV to cardiovascular disease.
Main Results:
- HIV infection is associated with a wide range of cardiovascular pathologies, including myocarditis, cardiomyopathy, accelerated atherosclerosis, and non-infectious endocarditis.
- Morphologic changes observed in the heart and vasculature can manifest as various clinical syndromes, such as heart failure, arrhythmias, and ischemic heart disease.
- Both direct viral effects and chronic inflammation play significant roles in HIV-associated cardiovascular disease.
- Certain antiretroviral therapies have also been implicated in contributing to cardiovascular risk.
Conclusions:
- HIV-associated cardiovascular pathology is a significant and growing clinical concern.
- Understanding the correlation between morphologic findings and clinical syndromes is crucial for effective patient management.
- Multidisciplinary approaches are needed to address the complex cardiovascular risks faced by individuals living with HIV.
- Further research is warranted to elucidate specific pathogenetic mechanisms and develop targeted preventive and therapeutic strategies.
Abstract:
More effective therapies have improved survival times of HIV+ patients, resulting in a higher prevalence of long-term complications of the disease. This review focuses on HIV-associated cardiovascular pathology, correlating the morphologic findings to clinical syndromes of HIV disease/AIDS.